Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
- 8 May 2009
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 24 (7) , 795-801
- https://doi.org/10.1007/s11606-009-0989-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Soft Targets: Nurses and the Pharmaceutical IndustryPLoS Medicine, 2008
- Characteristics of Recipients of Free Prescription Drug Samples: A Nationally Representative AnalysisAmerican Journal of Public Health, 2008
- The Rosiglitazone Story — Lessons from an FDA Advisory Committee MeetingNew England Journal of Medicine, 2007
- A National Survey of Physician–Industry RelationshipsNew England Journal of Medicine, 2007
- Following the Script: How Drug Reps Make Friends and Influence DoctorsPLoS Medicine, 2007
- Physicians and Drug Representatives: Exploring the Dynamics of the RelationshipJournal of General Internal Medicine, 2007
- New Effort to Develop Molecular Tools for Early Cancer Detection Under WayJAMA, 2005
- Pharmaceutical Gift GivingJONA: The Journal of Nursing Administration, 2003
- Physicians' Perceptions and Uses of Commercial Drug Information SourcesHealth Marketing Quarterly, 2001
- The role and value of pharmaceutical marketingArchives of Family Medicine, 1994